I-aβ Gene Expression Regulation in Macrophages Derived from Mice Susceptible or Resistant to Infection with M. Bovis BCG

Molecular Immunology

Volumn 34, Issue 4, 1997, Pages 343-355

  Barrera, L F ^a,b   Kramnik, I ^a,c   Skamene, E ^a   Radzioch, D ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c Albert Einstein   (United States)

Author keywords

Bcg gene; I A ; Macrophage activation; MHC class II; Nramp1

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN;

ALLELE; ANIMAL CELL; ARTICLE; DNA BINDING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; INFECTION RESISTANCE; MACROPHAGE; MACROPHAGE ACTIVATION; MYCOBACTERIOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, SURFACE; BINDING, COMPETITIVE; CELL LINE; CELL NUCLEUS; COLD; DISEASE SUSCEPTIBILITY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, NATURAL; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, INBRED A; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SPECIES SPECIFICITY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUBERCULOSIS;

ANIMALIA; MYCOBACTERIUM BOVIS BCG;

EID: 0030789488     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00018-7     Document Type: Article

References (71)

1. Albina J. E., Cui S., Mateo R. B. and Reichner J. S. (1993) Nitric oxide-mediated apoptosis in murine peritoneal macrophages. Journal of Immunology 150, 5080 5085.
2. Barrera L. F., Kramnik I., Skamene E. and Radzioch D. (1994) Nitrite production by macrophages derived from BCG-resistant and -susceptible mouse strains in response to IFN-γ and infection with BCG. Immunology 82, 457-464.
3. Barton H., White J. K., Roach T. I. A. and Blackwell J. M. (1994) NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. Journal of Experimental Medicine 179, 1683-1687.
4. Basta P. V., Sherman P. A. and Ting J. P. Y. (1987) Identification of an interferon-γ response region 5′ of the human histocompatibility leukocyte antigen DRa chain gene which is active in human glioblastoma multiforme lines. Journal of Immunology 138, 1275-1280.
5. Benoist C. and Mathis D. (1990) Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annual Review of Immunology 8, 681-715.
6. Blackwell J. M., Roach T. I. A., Atkinson S. E., Ajioka J. W., Barton C. H. and Shaw M. A. (1991) Genetic regulation of macrophage priming/activation: the Lsh gene story. Immunology Letters 30, 241-248.
7. Boothby M., Liou H. and Glimcher L. H. (1989) Differences in DNA sequence specificity among MHC class II X box binding proteins. Journal of Immunology 142, 1005-1014.
8. Bradley D. J. (1977) Genetic control of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to L. donovani infection. Clinical and Experimental Immunology 30, 130-140.
9. Bradley D. J., Taylor B. A., Blackwell J., Evans E. P. and Freeman J. (1979) Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to the visceral leishmaniasis in the mouse. Clinical and Experimental Immunology 37, 7-14.
10. Buschman E., Taniyama T., Nakamura R. and Skamene E. (1989) Functional expression of the Bcg gene in macrophages. Research in Immunology 140, 793-797.
11. Calman A. F. and Peterlin B. M. (1987) Mutant human B cell lines deficient in class II major histocompatibility complex transcription. Journal of Immunology 139, 2489-2495.
12. Celada A., Shiga M., Imagawa M., Kop J. and Maki R. (1988) Identification of a nuclear factor that binds to a conserved sequence of the I-A β gene. Journal of Immunology 140, 3995-4002.
13. Chirgwin J. M., Przybyla A. E., MacDonald R. J. and Rutter W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
14. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G. and Orme I. M. (1993) Disseminated tuberculosis in interferon γ gene-disrupted mice. Journal of Experimental Medicine 178, 2243-2247.
15. Corbett J. A., Tilton R. G., Chang K., Hasan K. S., Ido Y., Wang J. L., Sweetland M. A., Lancaster J. R. Jr, Williamson J. R. and McDaniel M. L. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41, 552-556.
16. Crocker P. R., Blackwell J. M. and Bradley, D. J. (1984) Expression of the natural resistance gene LSh in resistant liver macrophages. Infection and Immunity 43, 1033-1040.
17. Dalton D. K., Pitts-Meek S., Keshav S., Figari L. S., Bradley A. and Stewart T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ gene. Science 259, 1739-1742.
18. Dedrick R. L. and Jones P. P. (1990) Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell type-specific nuclear factors. Molecular and Cellular Biology 10, 593-604.
19. Denis M., Buschman E., Forget A., Pelletier M. and Skamene E. (1988) Pleiotropic effects of the Bcg gene. II. Genetic restriction of responses to mitogens and allogeneic targets. Journal of Immunology 141, 3988-3993.
20. Denis M., Forget A., Pelletier M. and Skamene E. (1988) Pleiotropic effects of the Bcg gene: III. Respiratory burst in Bcg-congenic macrophages. Clinical and Experimental Immunology 73, 370-375.
21. Dignam J. D., Levobitz R. M. and Roeder R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11, 1475-1489.
22. Dorn A., Bollekens J., Staub A., Benoist C. and Mathis D. (1987) A multiplicity of CCAAT box-binding proteins. Cell 50, 863-872.
23. Dorn A., Durand B., Marfing C., Le Meur M., Benoist C. and Mathis D. (1987) Conserved major histocompatibility complex class II boxes-X and -Y are transcriptional control elements and specifically bind nuclear proteins. Proceedings of the National Academy of Science U.S.A. 84, 6249-6253.
24. Farrar M. A. and Schreiber R. D. (1993) The molecular cell biology of interferon-γ and its receptor. Annual Reviews in Immunology 11, 571-611.
25. Forget A., Skamene E., Gros P., Miailhe A. and Turcotte R. (1981) Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG. Infection and Immunity 32, 42.
26. Freund Y. R., Dedrick R. L. and Jones P. (1990) cis-Acting sequences required for class II gene regulation by interferon γ and tumor necrosis factor α in a murine macrophage cell line. Journal of Experimental Medicine 111, 1283-1299.
27. Glimcher L. H. and Kara C. J. (1992) Sequences and factors: A guide to MHC class-II transcription. Annual Reviews in Immunology 10, 13-49.
28. Goto Y., Buschman E. and Skamene E. (1989) Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics 30, 218-221.
29. Govoni G., Vidal S., Gauthier S., Skamene E., Malo D. and Gros P. (1996) The Bcg/Ity/Lsh locus - genetic transfer of resistance to infection in C57B1/6 mice transgenic for Nramp1(Gly 169) allele. Infection and Immunity 64, 2923-2929.
30. Gros P., Skamene E. and Forget A. (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. Journal of Immunology 127, 2417-2421.
31. Gros P., Skamene E. and Forget A. (1983) Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis BCG. Journal of Immunology 131, 1966-1972.
32. Groudine M., Peretz M. and Weintraub H. (1981) Transcriptional regulation of hemoglobin switching in chicken embryos. Molecular and Cellular Biology 1, 281 288.
33. Johnson S. C. and Zwilling B. S. (1985) Continuous expression of I-A antigen by peritoneal macrophages from mice resistant to Mycobacterium bovis. Journal of Leukocyte Biology 38, 635-645.
34. Kamijo R., Le J., Shapiro D., Havell E. A., Huang S., Aguet M., Bosland M. and Vilcek J. (1993) Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. Journal of Experimental Medicine 178, 1435-1440.
35. Kara C. J. and Glimcher L. H. (1993) Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. Journal of Immunology 150, 4934-4942.
36. Kaye P. M., Sims M. and Feoldman M. (1986) Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti. Clinical and Experimental Immunology 64, 28-34.
37. Kern M. J., Stuart P. M., Omer K. W. and Woodward J. G. (1989) Evidence that IFN-gamma does not affect MHC class II gene expression at the post-transcriptional level in a mouse macrophage cell line. Immunogenetics 30, 258-265.
38. Klemsz M. J., McKercher S. R., Celada A., Van Beveren C. and Maki R. A. (1990) The macrophage and B-cell specific transcription factor PU.1 is related to the ets oncogene. Cell 61, 113-124.
39. Kouskoff V., Mantovani R. M., Candeias S. M., Dorn A., Staub A., Lisowska-Grospierre B., Griscelli C., Benoist C. O. and Mathis D. J. (1991) NF-X, a transcription factor implicated in MHC class II gene regulation. Journal of Immunology 146, 3197-3204.
40. Liou H., Polla B., Aragnol D., Leserman L. D., Griffith I. J. and Glimcher L. H. (1988) A tissue-specific DNase I-hypersensitive site in a class II I-Aα gene is under transregulatory control. Proceedings of the National Academy of Science U.S.A. 85, 2738-2742.
41. Maity S. N., Vuorio T. and De Crombrugghe B. (1990) The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast HAP2 transcription factor. Proceedings of the National Academy of Science U.S.A. 87, 5378-5382.
42. Mengle-Gaw L. and McDevitt H. O. (1985) Genetics and expression of mouse Ia antigens. Annual Reviews in Immunology 3, 367-396.
43. Misko T. P., Moore W. M., Kasten T. P., Nickols G. A., Corbett J. A., Tilton R. G., McDaniel M. L., Williamson J. R. and Currie M. G. (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. European Journal of Pharmacology 233, 119-125.
44. Miwa K., Doyle C. and Strominger J. L. (1987) Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes. Proceedings of the National Academy of Science U.S.A. 84, 4939-4943.
45. s mice. Cellular Immunology 111, 127-135.
46. Ombra M. N., Perfetto C., Autiero M., Anzisi A. M., Pasquinelli R., Maffei A., Del Pozzo G. and Guardiola J. (1993) Reversion of a transcriptionally defective MHC class II-negative human B cell mutant. Nucleic Acids Research 21, 381-386.
47. Plant J. E. and Glynn A. (1976) Genetics of resistance to infection with Salmonella typhimurium in mice. Journal of Infectious Diseases 133, 72-78.
48. Plant T. and Glynn A. A. (1979) Locating Salmonella resistance gene on mouse chromosome 1. Clinical and Experimental Immunology 37, 1-6.
49. Radzioch D., Hudson T., Boule M., Barrera L., Urbance J. W., Varesio L. and Skamene E. (1991) Genetic resistance/susceptibility to mycobacteria: Phenotypic expression in bone marrow-derived macrophage lines. Journal of Leukocyte Biology 50, 263-272.
50. Radzioch D., Kramnik I. and Skamene E. (1995) Molecular mechanisms of natural resistance to mycobacterial infections. Circulatory Shock 44, 115-120.
51. Reith W., Barras E., Satola S., Kobr M., Reinhart D., Herrero-Sanchez C. and Mach B. (1989) Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proceedings of the National Academy of Science U.S.A. 86, 4200-4204.
52. Roach T. I. A., Kiderlen A. F. and Blackwell J. (1991) Role of inorganic nitrogen oxides and tumor necrosis alpha in killing Leishmania donovani amastigotes in IFN-gamma-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infection and Immunity 59, 3935-3944.
53. Roach T. I. A., Chatterjee D. and Blackwell J. M. (1994) Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: Regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infection and Immunity 62, 1176-1184.
54. Schurr E., Radzioch D., Malo D., Gros P. and Skamene E. (1991) Molecular genetics of inherited susceptibility to intracellular parasites. Behring Institute Mitt. 88, 1-12.
55. Sittisombut N. (1988) Two distinct nuclear factors bind the conserved regulatory sequence of a rabbit major histocompatibility complex class II gene. Molecular and Cellular Biology 8, 2034-2041.
56. Skamene E., Gros P., Forget A., Kongshavn P. A. L., St Charles C. and Taylor B. A. (1982) Genetic regulation of resistance to intracellular pathogens. Nature 297, 506-510.
57. Stach J. L., Gros P., Forget A. and Skamene E. (1984) Phenotypic expression of genetically controlled natural resistance by Mycobacterium bovis (BCG). Journal of Immunology 132, 888-892.
58. Sullivan K. E., Calman A. F., Nakanishi M., Tsang S. Y., Wang Y. and Peterlin B. M. (1987) A model for the transcriptional regulation of MHC class II genes. Immunology Today 8, 289-293.
59. Thanos D., Mavrothalassitis G. and Papamatheakis J. (1988) Multiple regulatory regions on the 5′ side of the mouse E α gene. Proceedings of the National Academy of Science U.S.A. 85, 3075-3079.
60. Ting J. P. Y. and Baldwin A. S. (1993) Regulation of MHC gene expression. Current Opinions in Immunology 5, 8-16.
61. van Huijsduijnen R. H., Li X. Y., Black D., Matthes H., Benoist C. and Mathis D. (1990) Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO Journal 9, 3119-3127.
62. Vespa L., Johnson S. H., Aldrich W. A. and Zwilling B. S. (1987) Modulation of macrophage I-A expression: Lack of effect of prostaglandins and glucocorticoids on macrophages that continuously express I-A. Journal of Leukocyte Biology 41, 47-54.
63. s mice. Transient expression of I-A is due to degradation of MHC class II glycoproteins. Journal of Immunology 143, 214-220.
64. Vidai S., Malo D., Vogan K., Skamene E. and Gros P. (1993) Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 73, 469-485.
65. Vidai S., Gros P. and Skamene E. (1995) Natural resistance to infection with intracellular parasites: molecular genetics identifies Nrampl as Bcg/Ity/Lsh locus. Journal of Leukocyte Biology 58, 382-390.
66. Vidai S., Tremblay M. L., Govoni G., Gauthier S., Sebatini G., Malo D., Skamene E., Olivier M., Jothy S. and Gros P. (1995) The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites in abrogated by disruption of the Nrampl gene. Journal of Experimental Medicine 182, 655-666.
67. Walker W. S. and Sun D. (1991) Constitutive antigen presentation by mouse splenic macrophages is restricted to the progeny of a distinct progenitor population. Cellular Immunology 133, 342-351.
68. Wright K. L. and Ting J. P. Y. (1992) In vivo footprint analysis of the HLA-DRA gene promoter: Cell-specific interaction at the octamer site and up-regulation of X box binding by interferon γ. Proceedings of the National Academy of Science U.S.A. 89, 7601-7605.
69. Yang Z., Sugawara M., Ponath P. D., Wessendorf L., Banerji J., Li Y. and Strominger J. L. (1990) Interferon γ response region in the promoter of the human DPA gene. Proceedings of the National Academy of Science U.S.A. 87, 9226-9230.
70. Zhang X., Jabrane-Ferrat N., Asiedu C., Samac S., Peterlin B. M. and Ehrlich M. (1993) The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein. Molecular and Cellular Biology 13, 6810-6818.
71. Zwilling B. S., Vespa L. and Massie M. (1987) Regulation of I-A expression by murine peritoneal macrophages: Differences linked to the Bcg gene. Journal of Immunology 138, 1372-1376.